AbCellera Biologics Inc.
|
-0.51 USD
|
-282.353%
|
Alkermes plc
|
2.14 USD
|
191.121%
|
Agenus Inc.
|
-13.75 USD
|
85.818%
|
Aptorum Group Limited
|
-0.62 USD
|
-214.516%
|
Ardelyx, Inc.
|
-0.30 USD
|
-550.0%
|
Dyadic International, Inc.
|
-0.24 USD
|
-712.5%
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
-5242.466%
|
Lantern Pharma Inc.
|
-1.47 USD
|
-32.653%
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
45.378%
|
Novavax, Inc.
|
-5.41 USD
|
63.956%
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
-47.727%
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
-5.405%
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
98.118%
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
-323.913%
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
58.686%
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
90.245%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
-56.0%
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
-45.522%
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
66.437%
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
-2.094%
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
97.886%
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
-333.333%
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
-267.925%
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
26.966%
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
44.602%
|
AlloVir, Inc.
|
-1.83 USD
|
-6.557%
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
-2.094%
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
29.603%
|
Bicycle Therapeutics plc
|
-5.08 USD
|
61.614%
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
68.293%
|
ChromaDex Corporation
|
-0.07 USD
|
-2859.029%
|
Chimerix, Inc.
|
-0.93 USD
|
-109.677%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
81.086%
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
-41.304%
|
CRISPR Therapeutics AG
|
-1.94 USD
|
-0.515%
|
Precision BioSciences, Inc.
|
-15.96 USD
|
87.782%
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
-18.902%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
76.978%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
76.978%
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
77.404%
|
ImmuCell Corporation
|
-0.75 USD
|
-160.0%
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
0.51%
|
Immix Biopharma, Inc.
|
-0.89 USD
|
-119.101%
|
Incyte Corporation
|
2.67 USD
|
173.034%
|
Innoviva, Inc.
|
2.92 USD
|
166.781%
|
IO Biotech, Inc.
|
-1.98 USD
|
1.515%
|
Jaguar Health, Inc.
|
-107.42 USD
|
98.185%
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
62.5%
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
164.57%
|
ContextLogic Inc.
|
-13.36 USD
|
85.404%
|
MiMedx Group, Inc.
|
0.48 USD
|
506.25%
|
MEI Pharma, Inc.
|
2.67 USD
|
173.034%
|
NextCure, Inc.
|
-2.25 USD
|
13.333%
|
Onconetix, Inc.
|
-2.19 USD
|
10.959%
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
85.48%
|
Opthea Limited
|
-0.35 USD
|
-457.143%
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
75.159%
|
Vaxcyte, Inc.
|
-4.14 USD
|
52.899%
|
PDS Biotechnology Corporation
|
-1.39 USD
|
-40.288%
|
Precigen, Inc.
|
-0.39 USD
|
-400.0%
|
Pharming Group N.V.
|
-0.16 USD
|
-1118.75%
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
50.382%
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
91.055%
|
PureTech Health plc
|
-2.38 USD
|
18.067%
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
-35.417%
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
32.99%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
-56.0%
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
-31.757%
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
-93.069%
|
Acelyrin, Inc.
|
-5.43 USD
|
64.088%
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
-51215.789%
|
Summit Therapeutics Inc.
|
-0.99 USD
|
-96.97%
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
-59.836%
|
Senti Biosciences, Inc.
|
-16.01 USD
|
87.82%
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
18.067%
|
Elevation Oncology, Inc.
|
-1.34 USD
|
-45.522%
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
91.124%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
-343.182%
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
-875.0%
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
-28.289%
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
39.628%
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
-261.111%
|
Seer, Inc.
|
-1.35 USD
|
-44.444%
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
-31.757%
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
20.082%
|
ESSA Pharma Inc.
|
-0.60 USD
|
-225.0%
|
GlycoMimetics, Inc.
|
-0.58 USD
|
-236.207%
|
GT Biopharma, Inc.
|
-5.64 USD
|
65.426%
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
61.914%
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
-596.429%
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
391.045%
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
18.41%
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
-31.757%
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
86.753%
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
-42.336%
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
11.364%
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
-47.727%
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
33.219%
|
Aptose Biosciences Inc.
|
-7.58 USD
|
74.274%
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
99.821%
|
Soligenix, Inc.
|
-12.66 USD
|
84.597%
|
Century Therapeutics, Inc.
|
-2.30 USD
|
15.217%
|
Kura Oncology, Inc.
|
-2.08 USD
|
6.25%
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
-43.382%
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
-41.304%
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
-7314.449%
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
-25224.675%
|
Autolus Therapeutics plc
|
-1.20 USD
|
-62.5%
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
2.01%
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
-7.143%
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
52.206%
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
-25.0%
|
GRI Bio, Inc.
|
-28.25 USD
|
93.097%
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
28.044%
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
-16.071%
|
IGM Biosciences, Inc.
|
-4.71 USD
|
58.599%
|
INmune Bio, Inc.
|
-1.67 USD
|
-16.766%
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
-143.75%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
74.476%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
84.585%
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
95.927%
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
-40.288%
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
-242.105%
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
97.008%
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
22.925%
|
Verastem, Inc.
|
-3.96 USD
|
50.758%
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
22.925%
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
29.091%
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
99.11%
|
Histogen Inc.
|
-3.46 USD
|
43.642%
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
50.633%
|
Surrozen, Inc.
|
-21.33 USD
|
90.858%
|
Organovo Holdings, Inc.
|
-1.60 USD
|
-21.875%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
26.692%
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
-163.514%
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
99.999%
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
3.465%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
-214.516%
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
-24.204%
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
84.172%
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
-74.107%
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
21.053%
|
Apollomics, Inc.
|
-2.32 USD
|
15.948%
|
Amarin Corporation plc
|
-0.15 USD
|
-1200.0%
|
Mesoblast Limited
|
-0.89 USD
|
-119.101%
|
Turnstone Biologics Corp.
|
-4.77 USD
|
59.119%
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
22.619%
|
Synaptogenix, Inc.
|
-29.56 USD
|
93.403%
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
-1118.75%
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
-261.111%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-572.414%
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
-236.207%
|
Exelixis, Inc.
|
0.65 USD
|
400.0%
|
Better Therapeutics, Inc.
|
-1.69 USD
|
-15.385%
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
26.415%
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
56.18%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-509.375%
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
95.147%
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
-18.902%
|
Gritstone bio, Inc.
|
-1.20 USD
|
-62.5%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
68.447%
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
63.415%
|
Avid Bioservices, Inc.
|
-2.23 USD
|
12.556%
|
Insmed Incorporated
|
-5.34 USD
|
63.483%
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
84.965%
|
MediWound Ltd.
|
-0.75 USD
|
-160.0%
|
OmniAb, Inc.
|
-0.51 USD
|
-282.353%
|
Alector, Inc.
|
-1.56 USD
|
-25.0%
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
-119.101%
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
29.603%
|
Zai Lab Limited
|
-3.46 USD
|
43.642%
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
49.086%
|
Aura Biosciences, Inc.
|
-1.93 USD
|
-1.036%
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
-109.677%
|
Immunic, Inc.
|
-2.11 USD
|
7.583%
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
57.792%
|
Veracyte, Inc.
|
-1.02 USD
|
-91.176%
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
-93.069%
|
FibroGen, Inc.
|
-2.92 USD
|
33.219%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
93.562%
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
64.154%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
89.25%
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
128.058%
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
92.71%
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
367.123%
|
TG Therapeutics, Inc.
|
0.09 USD
|
2283.651%
|
Galecto, Inc.
|
-36.08 USD
|
94.595%
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
75.441%
|
Fortrea Holdings Inc.
|
-0.04 USD
|
-4991.384%
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
43.314%
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
96.886%
|
XBiotech Inc.
|
-0.81 USD
|
-140.741%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
68.447%
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
-54.762%
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
16.667%
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
-297.959%
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
-95.0%
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
76.364%
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
-7.143%
|
Vaxxinity, Inc.
|
-0.45 USD
|
-333.333%
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
-65.254%
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
-14.035%
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
95.411%
|
NexImmune, Inc.
|
-30.82 USD
|
93.673%
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
48.138%
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
-1.036%
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
105.263%
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
5.34%
|
Scopus BioPharma Inc.
|
-0.55 USD
|
-254.545%
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
36.066%
|
Ainos, Inc.
|
-3.36 USD
|
41.964%
|
Pluri Inc.
|
-3.99 USD
|
51.128%
|
Prothena Corporation plc
|
-2.76 USD
|
29.348%
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
-242.105%
|
Celularity Inc.
|
-11.02 USD
|
82.305%
|
Rallybio Corporation
|
-1.84 USD
|
-5.978%
|
Cue Biopharma, Inc.
|
-1.11 USD
|
-75.676%
|
MeiraGTx Holdings plc
|
-1.49 USD
|
-30.872%
|
Omeros Corporation
|
-1.88 USD
|
-3.723%
|
Humacyte, Inc.
|
-1.07 USD
|
-82.243%
|
Immunocore Holdings plc
|
-1.13 USD
|
-72.566%
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
-4.839%
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
62.857%
|
Blueprint Medicines Corporation
|
-8.37 USD
|
76.703%
|
CalciMedica, Inc.
|
-7.65 USD
|
74.51%
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
-18.182%
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
25.856%
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
2.01%
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
-33.562%
|
Pulmatrix, Inc.
|
-3.87 USD
|
49.612%
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
71.983%
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
8.451%
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
64.022%
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
73.14%
|
Cytokinetics, Incorporated
|
-5.45 USD
|
64.22%
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
88.288%
|
Nutriband Inc.
|
-0.69 USD
|
-182.609%
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
45.378%
|
Vor Biopharma Inc.
|
-1.75 USD
|
-11.429%
|
Roivant Sciences Ltd.
|
5.55 USD
|
135.135%
|
Evogene Ltd.
|
-5.23 USD
|
62.715%
|
ProKidney Corp.
|
-0.57 USD
|
-242.105%
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
-37.324%
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
15.217%
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
50.633%
|
CorMedix Inc.
|
-0.91 USD
|
-114.286%
|
BioLineRx Ltd.
|
-0.94 USD
|
-107.447%
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
-80.556%
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
-163.514%
|
Atai Life Sciences N.V.
|
-0.25 USD
|
-680.0%
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
-132.143%
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
32.056%
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
56.376%
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
26.692%
|
MediciNova, Inc.
|
-0.17 USD
|
-1047.059%
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
89.567%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-195.455%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
80.92%
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
62.998%
|
Biomea Fusion, Inc.
|
-3.44 USD
|
43.314%
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
76.703%
|
Mereo BioPharma Group plc
|
-0.04 USD
|
-4262.416%
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
47.154%
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
34.564%
|
Absci Corporation
|
-1.20 USD
|
-62.5%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
51.005%
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
24.419%
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
50.633%
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
1075.0%
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
40.909%
|
Allakos Inc.
|
-2.14 USD
|
8.879%
|
Imunon, Inc.
|
-2.16 USD
|
9.722%
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
-22.642%
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
291.176%
|
BioAtla, Inc.
|
-2.58 USD
|
24.419%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-509.375%
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
94.203%
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
6.699%
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
-132.143%
|
XOMA Corporation
|
-4.04 USD
|
51.733%
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
-39.286%
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
10.959%
|
aTyr Pharma, Inc.
|
-0.94 USD
|
-107.447%
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
44.602%
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
32.526%
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
63.277%
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
-50.0%
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
23.228%
|
Akari Therapeutics, Plc
|
-2.04 USD
|
4.412%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-487400.0%
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
191.549%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
-93.069%
|
UroGen Pharma Ltd.
|
-3.55 USD
|
45.07%
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
-9.551%
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
57.609%
|
Orgenesis Inc.
|
-1.91 USD
|
-2.094%
|
Entera Bio Ltd.
|
-0.31 USD
|
-529.032%
|
GH Research PLC
|
-0.68 USD
|
-186.765%
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
24.419%
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
92.271%
|
Xencor, Inc.
|
-2.08 USD
|
6.25%
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
-105.263%
|
Replimune Group, Inc.
|
-3.24 USD
|
39.815%
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
-134.94%
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
4562.243%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
-93.069%
|
Portage Biotech Inc.
|
-3.70 USD
|
47.297%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-195.455%
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
8.879%
|
OncoCyte Corporation
|
-3.75 USD
|
48.0%
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
20.732%
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
77.005%
|
Purple Biotech Ltd.
|
-0.09 USD
|
-2071.492%
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
-214.516%
|
scPharmaceuticals Inc.
|
-1.42 USD
|
-37.324%
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
-37.324%
|
HilleVax, Inc.
|
-3.04 USD
|
35.855%
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
-134.94%
|
Tharimmune, Inc.
|
-107.08 USD
|
98.179%
|
Genprex, Inc.
|
-22.58 USD
|
91.364%
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
-30.872%
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
-712.5%
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
-58990.909%
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
-596.429%
|
OKYO Pharma Limited
|
-0.00 USD
|
-324900.0%
|
Savara Inc.
|
-0.33 USD
|
-490.909%
|
Curis, Inc.
|
-8.96 USD
|
78.237%
|
Daré Bioscience, Inc.
|
-4.15 USD
|
53.012%
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
-33.562%
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
73.684%
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
-30.0%
|
BeiGene, Ltd.
|
-8.45 USD
|
76.923%
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
90.892%
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
49.482%
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
-40.288%
|
Erasca, Inc.
|
-0.83 USD
|
-134.94%
|
bluebird bio, Inc.
|
-1.93 USD
|
-1.036%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
-69.565%
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
319.101%
|
DBV Technologies S.A.
|
-0.76 USD
|
-156.579%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
-69.565%
|
Moderna, Inc.
|
-12.34 USD
|
84.198%
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
-3.175%
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
-103.125%
|
Molecular Templates, Inc.
|
-1.80 USD
|
-8.333%
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
28.832%
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
-30.0%
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
25.856%
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
-57.258%
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
33.219%
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
19.421%
|
MacroGenics, Inc.
|
-0.15 USD
|
-1200.0%
|
RenovoRx, Inc.
|
-0.99 USD
|
-96.97%
|
Adicet Bio, Inc.
|
-3.31 USD
|
41.088%
|
Prime Medicine, Inc.
|
-2.18 USD
|
10.55%
|
Aditxt, Inc.
|
-4326.64 USD
|
99.955%
|
Adagene Inc.
|
-0.44 USD
|
-343.182%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-828.571%
|
Quantum-Si incorporated
|
-0.68 USD
|
-186.765%
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
-116.667%
|
Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
-69.565%
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
163.312%
|
SciSparc Ltd.
|
-14.43 USD
|
86.486%
|
Vericel Corporation
|
-0.07 USD
|
-2814.798%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-267.925%
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
57.701%
|
Generation Bio Co.
|
-1.96 USD
|
0.51%
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
19.421%
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
-3.723%
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
48.413%
|
Invivyd, Inc.
|
-1.81 USD
|
-7.735%
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
30.108%
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
79.772%
|
Spero Therapeutics, Inc.
|
0.43 USD
|
553.488%
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
44.126%
|
2seventy bio, Inc.
|
-4.42 USD
|
55.882%
|
ADMA Biologics, Inc.
|
-0.13 USD
|
-1400.0%
|
Clene Inc.
|
-9.43 USD
|
79.321%
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
-134.94%
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
12.162%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
80.92%
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
-23.418%
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
-786.364%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
243.382%
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
40.549%
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
95.815%
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
47.861%
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
57.516%
|
Evaxion Biotech A/S
|
-8.11 USD
|
75.956%
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
-78.899%
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
37.5%
|
Trevena, Inc.
|
-54.51 USD
|
96.423%
|
Surrozen, Inc.
|
-21.33 USD
|
90.858%
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
-20.37%
|
Cingulate Inc.
|
-311.99 USD
|
99.375%
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
93.511%
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
27.778%
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
93.728%
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
-53.543%
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
-427.027%
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
-80.556%
|
Clearmind Medicine Inc.
|
-59.18 USD
|
96.705%
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
-6.557%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-400.0%
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
-114.286%
|
Statera Biopharma, Inc.
|
-4.97 USD
|
60.765%
|
ImmunityBio, Inc.
|
-1.15 USD
|
-69.565%
|
Korro Bio, Inc.
|
-53.08 USD
|
96.326%
|
Kineta, Inc.
|
-1.28 USD
|
-52.344%
|
BioVie Inc.
|
-7.30 USD
|
73.288%
|
Codexis, Inc.
|
-1.12 USD
|
-74.107%
|
Celularity Inc.
|
-11.02 USD
|
82.305%
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
47.154%
|
Celcuity Inc.
|
-2.69 USD
|
27.509%
|
Virax Biolabs Group Limited
|
-3.36 USD
|
41.964%
|
Cibus, Inc.
|
-25.95 USD
|
92.486%
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
-121775.0%
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
88.088%
|
IN8bio, Inc.
|
-1.00 USD
|
-95.0%
|
Kodiak Sciences Inc.
|
-4.97 USD
|
60.765%
|
Annexon, Inc.
|
-1.77 USD
|
-10.169%
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
83.219%
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
85.426%
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
98.283%
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
23.828%
|
Eyenovia, Inc.
|
-0.66 USD
|
-195.455%
|
Puma Biotechnology, Inc.
|
0.46 USD
|
523.913%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-2057.08%
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
29.856%
|
Arcellx, Inc.
|
-1.47 USD
|
-32.653%
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
-109.677%
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
69.436%
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
-23.418%
|
Moolec Science SA
|
-1.50 USD
|
-30.0%
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
-80.556%
|
Geron Corporation
|
-0.32 USD
|
-509.375%
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
-24.204%
|
Royalty Pharma plc
|
3.41 USD
|
157.185%
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
-19.632%
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
-182.609%
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
83.544%
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
-31.757%
|
Humacyte, Inc.
|
-1.07 USD
|
-82.243%
|
Structure Therapeutics Inc.
|
-2.44 USD
|
20.082%
|
89bio, Inc.
|
-2.00 USD
|
2.5%
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
-35.417%
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
97.351%
|
Genelux Corporation
|
-1.16 USD
|
-68.103%
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
-572.414%
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
-143.75%
|
Notable Labs, Ltd.
|
-5.03 USD
|
61.233%
|
Liquidia Corporation
|
-1.21 USD
|
-61.157%
|
Mustang Bio, Inc.
|
-6.00 USD
|
67.5%
|
Immunovant, Inc.
|
-1.88 USD
|
-3.723%
|
Quantum-Si incorporated
|
-0.68 USD
|
-186.765%
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
-343.182%
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
-225.0%
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
13.333%
|
Acasti Pharma Inc.
|
-1.35 USD
|
-44.444%
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
-200.0%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
84.585%
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
28.571%
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
-387.5%
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
20.732%
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
-2.094%
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
17.373%
|
PepGen Inc.
|
-3.30 USD
|
40.909%
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
87.06%
|
United Therapeutics Corporation
|
21.04 USD
|
109.268%
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
-36.364%
|
Solid Biosciences Inc.
|
-4.83 USD
|
59.627%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-572.414%
|
Immuneering Corporation
|
-1.88 USD
|
-3.723%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
26.692%
|
Silo Pharma, Inc.
|
-1.20 USD
|
-62.5%
|
Belite Bio, Inc
|
-1.19 USD
|
-63.866%
|
XOMA Corporation
|
-4.04 USD
|
51.733%
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
-242.105%
|
Bionomics Limited
|
-1.02 USD
|
-91.176%
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
-57252.941%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-364.286%
|
uniQure N.V.
|
-6.47 USD
|
69.861%
|
Cassava Sciences, Inc.
|
-2.32 USD
|
15.948%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-828.571%
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
-42.336%
|
Forte Biosciences, Inc.
|
-24.92 USD
|
92.175%
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
-509.375%
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
-25.0%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-2057.08%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
93.562%
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
-230.508%
|
Altimmune, Inc.
|
-1.66 USD
|
-17.47%
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
-282.353%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-364.286%
|
Compugen Ltd.
|
-0.21 USD
|
-828.571%
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
-50.0%
|
Benitec Biopharma Inc.
|
-5.36 USD
|
63.619%
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
96.03%
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
63.755%
|
Zura Bio Limited
|
-2.09 USD
|
6.699%
|
PolyPid Ltd.
|
-16.99 USD
|
88.523%
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
42.982%
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
63.755%
|
Instil Bio, Inc.
|
-24.00 USD
|
91.875%
|
argenx SE
|
-5.16 USD
|
62.209%
|
Immunome, Inc.
|
-5.38 USD
|
63.755%
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
-490.909%
|
Verona Pharma plc
|
-0.54 USD
|
-261.111%
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
56.763%
|
Shattuck Labs, Inc.
|
-2.05 USD
|
4.878%
|
CervoMed Inc.
|
-0.82 USD
|
-137.805%
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
87.255%
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
54.009%
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
76.923%
|
Moolec Science SA
|
-1.50 USD
|
-30.0%
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
75.896%
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
67.98%
|
AnaptysBio, Inc.
|
-6.08 USD
|
67.928%
|
Design Therapeutics, Inc.
|
-1.19 USD
|
-63.866%
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
51.005%
|
NeurAxis, Inc.
|
-4.03 USD
|
51.613%
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
74.774%
|
Lumos Pharma, Inc.
|
-4.18 USD
|
53.349%
|
Achilles Therapeutics plc
|
-1.74 USD
|
-12.069%
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
56.763%
|
180 Life Sciences Corp.
|
-52.60 USD
|
96.293%
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
386.765%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-400.0%
|
Nutriband Inc.
|
-0.69 USD
|
-182.609%
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
0.51%
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
87.54%
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
1.515%
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
-46.617%
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
-167.123%
|
Palisade Bio, Inc.
|
-27.01 USD
|
92.78%
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
78.016%
|
Beam Therapeutics Inc.
|
-1.72 USD
|
-13.372%
|
Neurogene Inc.
|
-2.83 USD
|
31.095%
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
51.25%
|
AEON Biopharma, Inc.
|
- USD
|
Infinity%
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
18.067%
|
Sesen Bio, Inc.
|
-1.99 USD
|
2.01%
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
2.985%
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
91.959%
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
-3.175%
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
-103.125%
|
Athira Pharma, Inc.
|
-3.10 USD
|
37.097%
|
Vaccinex, Inc.
|
-43.68 USD
|
95.536%
|
HCW Biologics Inc.
|
-0.70 USD
|
-178.571%
|
XOMA Corporation
|
-4.04 USD
|
51.733%
|
Nektar Therapeutics
|
-1.45 USD
|
-34.483%
|
Arvinas, Inc.
|
-6.62 USD
|
70.544%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-487400.0%
|
Merus N.V.
|
-3.00 USD
|
35.0%
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
-8.333%
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
-132.143%
|
Rezolute, Inc.
|
-1.33 USD
|
-46.617%
|
Clene Inc.
|
-9.43 USD
|
79.321%
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
-5.978%
|
BeyondSpring Inc.
|
-0.54 USD
|
-261.111%
|
Synlogic, Inc.
|
-8.81 USD
|
77.866%
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
-18832.039%
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
95.84%
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
-85.714%
|
Krystal Biotech, Inc.
|
0.40 USD
|
587.5%
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
-56.0%
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
62.136%
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
-153.247%
|
MannKind Corporation
|
-0.04 USD
|
-4262.416%
|
Ikena Oncology, Inc.
|
-1.63 USD
|
-19.632%
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
78.309%
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
-38.298%
|
Gossamer Bio, Inc.
|
-1.18 USD
|
-65.254%
|
CohBar, Inc.
|
-4.13 USD
|
52.785%
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
-126.744%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
51.005%
|
Legend Biotech Corporation
|
-2.94 USD
|
33.673%
|
Mural Oncology plc
|
-12.43 USD
|
84.312%
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
75.222%
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
82.273%
|
Disc Medicine, Inc.
|
-3.43 USD
|
43.149%
|
Champions Oncology, Inc.
|
-0.54 USD
|
-261.111%
|
REGENXBIO Inc.
|
-6.02 USD
|
67.608%
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
58.422%
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
-225.0%
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
37.299%
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
-24.204%
|
Vaxart, Inc.
|
-0.57 USD
|
-242.105%
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
-8.333%
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
-204.688%
|
Cellectis S.A.
|
-1.77 USD
|
-10.169%
|
Longeveron Inc.
|
-10.22 USD
|
80.92%
|
Repare Therapeutics Inc.
|
-2.23 USD
|
12.556%
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
66.379%
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
-42.336%
|
Revolution Medicines, Inc.
|
-3.86 USD
|
49.482%
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
-2553.061%
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
-150.0%
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
10.138%
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
28.832%
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
-509.375%
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
113.879%
|
Denali Therapeutics Inc.
|
-1.06 USD
|
-83.962%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-267.925%
|
Veru Inc.
|
-1.10 USD
|
-77.273%
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
-248.214%
|
Cingulate Inc.
|
-311.99 USD
|
99.375%
|
Passage Bio, Inc.
|
-1.86 USD
|
-4.839%
|
Context Therapeutics Inc.
|
-1.50 USD
|
-30.0%
|
Exicure, Inc.
|
-2.11 USD
|
7.583%
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
17.722%
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
-101.031%
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
88.267%
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
39.063%
|
Nuvalent, Inc.
|
-2.17 USD
|
10.138%
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
19.753%
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
24.71%
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
-52.344%
|
OmniAb, Inc.
|
-0.51 USD
|
-282.353%
|
Anew Medical, Inc.
|
0.14 USD
|
1492.857%
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
-225.0%
|
Lipocine Inc.
|
-3.14 USD
|
37.898%
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
21.687%
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
-282.353%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
74.476%
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
-109.677%
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
6.25%
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
78.453%
|
Ocugen, Inc.
|
-0.26 USD
|
-650.0%
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
20.082%
|
Q32 Bio Inc.
|
-35.16 USD
|
94.454%
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
-387.5%
|
Alumis Inc. Common Stock
|
-2.99 USD
|
34.783%
|
Equillium, Inc.
|
-0.38 USD
|
-413.158%
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
-1949900.0%
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
-146.835%
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
99.224%
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
-46.617%
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
92.58%
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
-10.795%
|
Dominari Holdings Inc.
|
-4.38 USD
|
55.479%
|
Edesa Biotech, Inc.
|
-2.93 USD
|
33.447%
|
vTv Therapeutics Inc.
|
-9.71 USD
|
79.918%
|
Bio-Techne Corporation
|
1.07 USD
|
282.243%
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
69.194%
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
189.862%
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
3.465%
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
-48.855%
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
38.095%
|
Nkarta, Inc.
|
-2.40 USD
|
18.75%
|
BioCardia, Inc.
|
-8.19 USD
|
76.19%
|
Iterum Therapeutics plc
|
-2.96 USD
|
34.122%
|